SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001469299-11-000194
Filing Date
2011-03-31
Accepted
2011-03-30 18:46:24
Documents
2
Period of Report
2011-03-27
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 BIOZONE FORM 8-K 03/29/11 biozoneform8k032911.htm 8-K 43193
2 PRESS RELEASE biozone991.htm EX-99.1 9933
  Complete submission text file 0001469299-11-000194.txt   54499
Mailing Address 4400 BISCAYNE BLVD SUITE 800 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD SUITE 800 MIAMI FL 33137 800-689-0930
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-146182 | Film No.: 11723378
SIC: 7389 Services-Business Services, NEC